Page 64 - Medication Guide News Today

How a young woman became empowered to improve her rheumatoid arthritis care Dec. 15, 2020 FacebookTwitterEmail (BPT) - At a young age, Randi learned the importance of self­-advocacy and honest conversations in the face of health struggles. Like most kids, she enjoyed sports and being active. When she was 10 years old, she started having pain in the joints of her knees, shoulders, and ankles. Doctors and coaches told her she was experiencing tendonitis. Randi would live silently with this pain ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization VIVUS, Inc.December 11, 2020 GMT CAMPBELL, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (the “Company”), a biopharmaceutical company, today announced that it has received approval from the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on its Second Amended Joint Prepackag...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending approval of BAVENCIO ® as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma who … – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Ger...

ABBVie today announced top-line results from the Phase 3b Heads Up study showing that upadacitinib achieved superiority to dupilumab for the primary endpoint, the proportion of patients with at least a 75 percent improvement in the Eczema Area Severity Index at week 16, in adults with moderate to severe atopic dermatitis. 1 Of patients treated with upadacitinib, 71 percent achieved EASI 75 at week 16 compared to 61 … ABBVie (NYSE: ABBV) today announced top-line results from the Phase 3b Heads...